drugset / Trial / NCT00656097
A Randomized Phase II Trial to Compare the Safety and Neutralizing Activity of CL184 in Combination With Rabies Vaccine vs. HRIG or Placebo in Combination With Rabies Vaccine in Healthy Adult Subjects
RandomizedParallel-groupSingle-blindTreatment
Summary
The aim of this study is to evaluate the safety of the monoclonal antibody cocktail CL184 in combination with rabies vaccine compared with human rabies immune globulin (HRIG) or placebo in combination with rabies vaccine in healthy adult subjects.
Timeline
- Start
- 2008-03
- Primary completion
- 2008-07
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CL184 | Monoclonal antibody | 20 iu/kg | Intramuscular |
| Comparator | human rabies immune globulin | Unknown | 20 iu/kg | Intramuscular |